Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANRS 159 VIH-2: Raltegravir, Emtricitabine and Tenofovir in HIV-2
NCT01605890Phase 2Completed
- Sponsor
- ANRS
- Start
- Jul 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltegravir in human immunodeficiency virus type 2 infection (HIV-2), sponsored by ANRS. Started Jul 2012; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus type 2 infection (HIV-2)
Beyond the preview
Go deeper on NCT01605890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01605890.